Gene therapies can be life changing. The final manufacturing step, aseptic filling, deserves the same attention as the rest of your process. It’s critical to ensure it is done reproducibly, without contaminating or compromising quality all while minimizing line loss. The stakes are high – patients are waiting.
Cytiva’s Aseptic Filling Workcells use an automated robotic process that removes the need for human intervention and allows them to be completely closed from end-to-end with no glove ports. This reduces the risk of contamination in gene therapy manufacturing and maintains drug product quality.
Scale quickly and economically
When developing potentially life-saving therapies, you want the ability to scale. Our standardized workcells can be added quickly, allowing you to scale out to move from development to commercialization. Our machines are also fitted with a dynamic peristaltic pump for fast, accurate filling that minimizes line loss.